Clinical Trials Directory

Trials / Completed

CompletedNCT00213421

Comparison of Two Therapeutic Strategies of Dermoval in Treatment of Bullous Pemphigus

Status
Completed
Phase
Study type
Observational
Enrollment
330 (actual)
Sponsor
University Hospital, Rouen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

to compare efficacity and tolerance of two stratégies of dermoval application in treatment of bullous pemphigus.

Conditions

Interventions

TypeNameDescription
DRUGDermovalgroup 1 elevated corticosteroids : attack treatment 2 tubes of 10g (4t/d) decreasing treatment : one month: 2 tubes/J (2t/d); 2 months : 2 tubes 1d sur 2 (1d/j); 4 months : 2 tubes 2 fois /week (0,6t/d); 4 months : 2 tubes 1 fois /week (0,3t/d)fois /week (0,3t/d) group 2 low corticosteroids : for paucibullous form with weight \< 45kg attack treatment 1 tubes of 10g (1t/d)decreasing treatment 1 month : 1 tube every 2d (0,5t/d; 1 month : 1 tubes 2 fois /week (0,3t/d) 1 month : 1 tubes 1 fois/week (0,15t/d); for paucibullous form with weight \> 45kg or for multibullous form with weight \< 45kg attack treatment 2 tubes of 10g (2t/d)decreasing treatment 1 month : 2 tubes every 2j (1t/d; 1 month : 2 tubes 2 fois /week (0,6t/d) 1 month : 2 tubes 1 fois /week (0,3t/d)and for multibullous form attack with weigth \> 45kg treatment 3 tubes of 10g (3t/d)decreasing treatment 1 month : 3 tubes every 2days (1,5t/d) 1 month : 3 tubes 2 fois /week (1t/j)1 mois : 3 tubes 1 fois /week (0,45t/d)

Timeline

Start date
2001-08-01
Primary completion
2004-10-01
Completion
2008-11-01
First posted
2005-09-21
Last updated
2013-06-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00213421. Inclusion in this directory is not an endorsement.